Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Mariana Oncology is a biotechnology research industry.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
IgGenix is a biotechnology company.
Rimidi is a health IT platform that enables virtual, personalized management of cardiometabolic diseases.
Amphista Therapeutics operates as a biopharmaceutical company.
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Arkuda Therapeutics is a pharmaceutical company.
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues
Eli Lilly has invested in 169 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 21 different industry categories.
Among tracked funding rounds, AbCellera received $515.8M in a Grant round. Eli Lilly's total known invested capital is $11.1B.
Eli Lilly's average investment size is $69.2M across its portfolio of 169 companies.
Recent Eli Lilly portfolio additions include Firefly Bio, Prism BioLab, GenEdit, Verve Therapeutics, Sitryx Therapeutics. These companies were founded in 2020 or later.